Protective effects of astragaloside IV against hypoxic pulmonary hypertension
Hypoxia
DOI:
10.1039/c8md00341f
Publication Date:
2018-09-04T12:05:39Z
AUTHORS (4)
ABSTRACT
Treatment with As-IV significantly decreased mPAP, RVP and RV/(LV + S) attenuated the development of HPH.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....